Procyrion, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1
Ending by 2030
Dec 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 11, 2027The maintenance fee for Support structures for intravascular blood pumps (US 11,697,017) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
- 2 fees due Apr 10 to 15, 2027 · next Apr 10
- 1 fee due Jun 10, 2027The maintenance fee for Systems and methods for fluid flows and/or pressures for circulation and perfusion enhancement (US 10,500,323) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 1 fee due Jul 2, 2027The maintenance fee for Blood Pumps (US 11,857,777) comes due Jul 2, 2027. Unpaid by Jan 3, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,012,079 | Method and apparatus for long-term assisting a left ventricle to pump blood In force · From the USPTO record | In force | From the USPTO record | |
| US 10,500,323 | Systems and methods for fluid flows and/or pressures for circulation and perfusion enhancement In force · From the USPTO record | In force | From the USPTO record | |
| US 9,572,915 | Systems and methods for fluid flows and/or pressures for circulation and perfusion enhancement In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 12,078,192 | Non-Occluding Intravascular Blood Pump Providing Reduced Hemolysis In force · High confidence | In force | High confidence | |
| US 12,736,054 | Non-Occluding Intravascular Blood Pump Providing Reduced Hemolysis In force · High confidence | In force | High confidence | |
| US 10,443,738 | Magnetic Fluid Seal for Implantable Devices In force · High confidence | In force | High confidence | |
| US 11,235,138 | Non-Occluding Intravascular Blood Pump Providing Reduced Hemolysis In force · High confidence | In force | High confidence | |
| US 11,324,940 | Blood Pumps In force · Medium confidence | In force | Medium confidence | |
| US 11,351,359 | Support structures for intravascular blood pumps In force · From the USPTO record | In force | From the USPTO record | |
| US 11,452,859 | Blood Pumps In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 18: 4 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
5 pending · 2 no status recorded